These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25618016)

  • 21. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
    Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
    Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids.
    Gao F; Yang H; Lu T; Chen Z; Ma L; Xu Z; Schaffer P; Lu G
    Eur J Med Chem; 2018 Nov; 159():277-281. PubMed ID: 30296686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity.
    Reddy DS; Kongot M; Kumar A
    Tuberculosis (Edinb); 2021 Mar; 127():102050. PubMed ID: 33540334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
    Campaniço A; Moreira R; Lopes F
    Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives.
    Liu YX; Xiao CL; Wang YX; Li YH; Yang YH; Li YB; Bi CW; Gao LM; Jiang JD; Song DQ
    Eur J Med Chem; 2012 Jun; 52():151-8. PubMed ID: 22503208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arylnitro monocarbonyl curcumin analogues: Synthesis and in vitro antitubercular evaluation.
    du Preez C; Legoabe LJ; Jordaan A; Jesumoroti OJ; Warner DF; Beteck RM
    Chem Biol Drug Des; 2023 Mar; 101(3):717-726. PubMed ID: 36350112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
    Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products.
    Rossi I; Bettini R; Buttini F
    Curr Pharm Des; 2021; 27(12):1436-1452. PubMed ID: 33480336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
    Barilar I; Fernando T; Utpatel C; Abujate C; Madeira CM; José B; Mutaquiha C; Kranzer K; Niemann T; Ismael N; de Araujo L; Wirth T; Niemann S; Viegas S
    Lancet Infect Dis; 2024 Mar; 24(3):297-307. PubMed ID: 37956677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB].
    Zhang LL; Yang H; Xiao HP; Lu JM; Sha W; Zhang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):464-8. PubMed ID: 27289577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activity of a new monocarbonyl analog of curcumin MAC 4 is associated with divisome disruption.
    Polaquini CR; Marques BC; Ayusso GM; Morão LG; Sardi JCO; Campos DL; Silva IC; Cavalca LB; Scheffers DJ; Rosalen PL; Pavan FR; Ferreira H; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104668. PubMed ID: 33601139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
    Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
    Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant
    Dehestani S; Davoodi J; Emami SA; Seddighinia FS; Sahebkar A; Soleimanpour S
    Comb Chem High Throughput Screen; 2022; 25(5):870-876. PubMed ID: 33588723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis.
    Juárez-Hernández RE; Franzblau SG; Miller MJ
    Org Biomol Chem; 2012 Oct; 10(37):7584-93. PubMed ID: 22895786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
    Changtam C; Hongmanee P; Suksamrarn A
    Eur J Med Chem; 2010 Oct; 45(10):4446-57. PubMed ID: 20691508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
    Wang A; Huang G; Wang B; Lv K; Wang H; Tao Z; Liu M; Guo H; Lu Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2945-2948. PubMed ID: 30006066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.